These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15448478)

  • 1. Potential use of (1,3)-beta-D-glucan as target of diagnosis and treatment of keratomycosis.
    Kaji Y; Hiraoka T; Oshika T
    Cornea; 2004 Nov; 23(8 Suppl):S36-41. PubMed ID: 15448478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful topical application of a new antifungal agent, micafungin, in the treatment of refractory fungal corneal ulcers: report of three cases and literature review.
    Matsumoto Y; Dogru M; Goto E; Fujishima H; Tsubota K
    Cornea; 2005 Aug; 24(6):748-53. PubMed ID: 16015098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits.
    Hiraoka T; Kaji Y; Wakabayashi T; Nanbu PN; Okamoto F; Oshika T
    Cornea; 2007 Apr; 26(3):336-42. PubMed ID: 17413962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety.
    Wiederhold NP; Lewis JS
    Expert Opin Pharmacother; 2007 Jun; 8(8):1155-66. PubMed ID: 17516879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micafungin.
    Jarvis B; Figgitt DP; Scott LJ
    Drugs; 2004; 64(9):969-82; discussion 983-4. PubMed ID: 15101786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micafungin sodium, the second of the echinocandin class of antifungals: theory and practice.
    Vehreschild JJ; Cornely OA
    Future Microbiol; 2006 Aug; 1(2):161-70. PubMed ID: 17661660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of FK463, a (1,3)-beta-D-glucan synthase inhibitor, in disseminated azole-resistant candida albicans infection in mice.
    Maesaki S; Hossain MA; Miyazaki Y; Tomono K; Tashiro T; Kohno S
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1728-30. PubMed ID: 10817741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antifungal activity and clinical efficacy of micafungin sodium (Funguard)].
    Ikeda F
    Nihon Yakurigaku Zasshi; 2003 Oct; 122(4):339-44. PubMed ID: 14501170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model.
    Goldblum D; Frueh BE; Sarra GM; Katsoulis K; Zimmerli S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1359-63. PubMed ID: 15793112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent Dosing of Micafungin Is Effective for Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits.
    Petraitiene R; Petraitis V; Hope WW; Walsh TJ
    Clin Infect Dis; 2015 Dec; 61 Suppl 6(Suppl 6):S643-51. PubMed ID: 26567283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micafungin: a new echinocandin.
    Chandrasekar PH; Sobel JD
    Clin Infect Dis; 2006 Apr; 42(8):1171-8. PubMed ID: 16575738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of micafungin in the antifungal armamentarium.
    Ikeda F; Tanaka S; Ohki H; Matsumoto S; Maki K; Katashima M; Barrett D; Aoki Y
    Curr Med Chem; 2007; 14(11):1263-75. PubMed ID: 17504145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echinocandins in the management of invasive fungal infections, Part 2.
    Morris MI; Villmann M
    Am J Health Syst Pharm; 2006 Oct; 63(19):1813-20. PubMed ID: 16990627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative evaluation of properties and clinical efficacy of the echinocandins.
    Kim R; Khachikian D; Reboli AC
    Expert Opin Pharmacother; 2007 Jul; 8(10):1479-92. PubMed ID: 17661730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micafungin: pharmacology, experimental therapeutics and clinical applications.
    Groll AH; Stergiopoulou T; Roilides E; Walsh TJ
    Expert Opin Investig Drugs; 2005 Apr; 14(4):489-509. PubMed ID: 15882123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitors.
    Georgopapadakou NH
    Expert Opin Investig Drugs; 2001 Feb; 10(2):269-80. PubMed ID: 11178340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis.
    Petraitiene R; Petraitis V; Hope WW; Mickiene D; Kelaher AM; Murray HA; Mya-San C; Hughes JE; Cotton MP; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4121-9. PubMed ID: 18779361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbits.
    Harrison JM; Glickman RD; Ballentine CS; Trigo Y; Pena MA; Kurian P; Najvar LK; Kumar N; Patel AH; Sponsel WE; Graybill JR; Lloyd WC; Miller MM; Paris G; Trujillo F; Miller A; Melendez R
    Doc Ophthalmol; 2005 Jan; 110(1):37-55. PubMed ID: 16249956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful treatment with micafungin (MCFG) of severe peritonitis due to Candida parapsilosis with chronic renal failure patient on hemodialysis].
    Hashimoto H; Moriya R; Kamata K; Higashihara M; Yoshida K; Kume H
    Kansenshogaku Zasshi; 2005 Mar; 79(3):195-200. PubMed ID: 15977561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of chronic mucocutaneous candidasis cured with micafungin].
    Suzuki T; Imamura A
    Kansenshogaku Zasshi; 2005 Feb; 79(2):143-8. PubMed ID: 15977552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.